Showing results (71-80 of 97) with videos related to

Sort By:
Pageof 10
Acta Oncologica (Stockholm, Sweden)|May 5, 1999
FEC mobilized stem cells for high-dose therapy in breast cancer patients. SB6 9401 Study GroupH Lindman, T Wiklund, H Holte, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|September 10, 1996
[High-dose therapy of cancer with CD34 positive cells as stem cell support]G Kvalheim, A Pharo, H Holte, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|September 10, 1996
[High dose therapy with autologous stem cell support in malignant disorders. Excerpt from the statement by the advisory group of the State Health Services]H Holte, S O Kvaløy, T Engan, et al.
International Journal of Cancer|December 15, 1989
Ki67 and 4F2 antigen expression as well as DNA synthesis predict survival at relapse/tumour progression in low-grade B-cell lymphomaH Holte, C de Lange Davies, K Beiske, et al.
European Journal of Cancer (Oxford, England : 1990)|February 14, 2004
Knowledge of and attitudes toward complementary and alternative therapies; a national multicentre study of oncology professionals in NorwayT Risberg, A Kolstad, Y Bremnes, et al.
Journal of Hematotherapy|August 1, 1996
Purging of tumor cells from leukapheresis products: experimental and clinical aspectsG Kvalheim, M Y Wang, A Pharo, et al.
Bone Marrow Transplantation|May 22, 2001
High-dose therapy with autologous stem cell transplantation in patients with peripheral T cell lymphomasA K Blystad, G Enblad, S Kvaløy, et al.
Blood Cancer Journal|August 26, 2017
Alternative splicing discriminates molecular subtypes and has prognostic impact in diffuse large B-cell lymphomaS-K Leivonen, M Taskinen, A Cervera, et al.
Pageof 10